Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1

Status

Completed 2Not yet recruiting 1

Sponsor Class

OTHER 3INDUSTRY 2

Study Type

Interventional 3

Sponsor

Cancer Type

Head & Neck 1Gynecologic 1Breast 1

Conditions

Triple Negative Breast Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Endometrial Neoplasms 1

Interventions

Specimen Handling 74Magnetic Resonance Spectroscopy 73Cyclophosphamide 69pembrolizumab 57Nivolumab 49Radiotherapy 48fludarabine 41Cisplatin 39Standard of Care 34Carboplatin 33Biopsy 33Bevacizumab 29Dexamethasone 28Rituximab 25Radiation 25Temozolomide 24Surveys and Questionnaires 24Radiosurgery 24Practice Guidelines as Topic 24Gemcitabine 24Doxorubicin 24Blood Specimen Collection 24venetoclax 23Cytarabine 23fludarabine phosphate 22Paclitaxel 21atezolizumab 20Ipilimumab 20Interviews as Topic 19Fluorouracil 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × CP protocol × 30 days × Clear all
NCT07610525 2026-05-28

Blood and imagE-guided Optimization of Neoadjuvant Therapy in People With Early Stage Triple-negative Breast cancER - the BETTER Trial

M.D. Anderson Cancer Center

Phase 2 Not yet recruiting
200 enrolled
Breast

Triple Negative Breast Neoplasms

NCT05294900 2026-05-26

NEOS

Yonsei University

Phase 2 Completed
79 enrolled 6 charts
Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT06102252 2026-05-22

Combination Chemotherapy of Paclitaxel and Carboplatin With or Without Anthracycline as Aneo Adjuvant Treatment in Advanced Endometrial Carcinoma

Sohag University

Phase NA Completed
60 enrolled
Gynecologic

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡